Showing results (951-960 of 1,021) with videos related to
Sort By:
Pageof 103
BMC Medicine|November 8, 2023
Can we achieve better trial recruitment by presenting patient information through multimedia? Meta-analysis of 'studies within a trial' (SWATs)Vichithranie W Madurasinghe, Peter Knapp, Sandra Eldridge, et al.AJNR. American Journal of Neuroradiology|January 2, 2025
Automated Detection of Normal Pressure Hydrocephalus Using CT Imaging for Calculating the Ventricle-to-Subarachnoid Volume RatioJacob J Knittel, Justin L Hoskin, Dylan J Hoyt, et al.Immunotherapy Advances|December 11, 2024
High-affinity T cell receptor ImmTAC® bispecific efficiently redirects T cells to kill tumor cells expressing the cancer-testis antigen PRAMEAna R Ribeiro, Camille Britton-Rivet, Laura Collins, et al.Nature Immunology|February 2, 2016
CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursorsLokesh A Kalekar, Shirdi E Schmiel, Sarada L Nandiwada, et al.BMC Cancer|November 16, 2019
PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinomaHannah L Buckley, Fiona J Collinson, Gemma Ainsworth, et al.Vaccine|October 11, 2005
A randomized controlled trial of a replication defective (gH deletion) herpes simplex virus vaccine for the treatment of recurrent genital herpes among immunocompetent subjectsGuy de Bruyn, Mauricio Vargas-Cortez, Terri Warren, et al.JCI Insight|May 19, 2017
T cell progenitor therapy-facilitated thymopoiesis depends upon thymic input and continued thymic microenvironment interactionMichelle J Smith, Dawn K Reichenbach, Sarah L Parker, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 19, 2015
Effect of Condom Use on Per-act HSV-2 Transmission Risk in HIV-1, HSV-2-discordant CouplesAmalia S Magaret, Andrew Mujugira, James P Hughes, et al.The Lancet. Oncology|May 19, 2015
Vismodegib in patients with advanced basal cell carcinoma (STEVIE): a pre-planned interim analysis of an international, open-label trialNicole Basset-Seguin, Axel Hauschild, Jean-Jacques Grob, et al.Genome Announcements|June 23, 2018
Complete Sequences of the Human T-Cell Leukemia Virus Type 1 Proviral Genomes from Newly Established Adult T-Cell Leukemia Cell Lines in Oita Prefecture, JapanTakuro Fukumoto, Emi Ikebe, Masao Ogata, et al.Pageof 103